|
|
|
|
Myasthenia gravis (MG) is an un-common disorder of immune pathogenesis affecting neuromuscular transmission. The prevalence is 0.5-5.0 per 100,000 population. The fluctuating nature of myasthenic weakness and its myriad presentations make it a unique clinical disorder. Occasionally it presents as an acute exacerbation involving respiratory muscles which may be potentially fatal, unless managed energetically. |
|